Francois Paris, Ph.D., director of the Endothelium Radiobiology and Targeting Laboratory, Cancer Research Center UMR Inserm 892 CNRS 6200, and the Clinical Cancer Center, ICO, in Nantes, France, will present IU Simon Cancer Center Grand Rounds from 8 a.m. to 9 a.m. Friday, April 5, in the Indiana Cancer Pavilion, Room 101.
The title of this presentation will be "Enhancement of radiotherapy efficacy by the modulation of the sphingolipid metabolic pathway."
Dr. Paris is a radiation biologist who has trained in prestigious research Centers such as the Curie Institute (Paris), MRC (Oxford), CEA (Paris) and Memorial Sloan-Kettering (New York). Since 2005, he has served as director of the endothelium radiobiology and targeting laboratory, a joint laboratory hosted in the Inserm Cancer Research Center and the Radiation Oncology department of the Clinical Cancer Center, ICO, Nantes, France. His main research area is focused to optimize radiation oncology treatment by deciphering the molecular events in the endothelial cells to enhance regression of irradiated tumors and/or to protect surrounding normal tissues.
Dr. Paris is also the author of more than 40 peer-reviewed publications in high impact scientific journals, including Science, Nature Medicine, Cancer Research.
There are no upcoming dates for this event.